Oncology Institute Completes Business Combination with DFP Healthcare Acquisitions

DFP Healthcare Acquisitions

The Oncology Institute closed its business combination with DFP Healthcare Acquisitions. DFP shareholders approved the deal Nov. 12.

The Oncology Institute will be led by its existing management team. Shares and warrants begin trading today on the Nasdaq under TOI and TOIIW.

The transaction implies an enterprise value for TOI of $842 million. TOI raised approximately $334 million in cash, including a $275 million PIPE. Approximately $133 million will be retained on TOI’s balance sheet to fund growth initiatives, including de novo clinics and acquisitions. Read more.

Total
0
Shares
Related Posts
Read More

PropTech Investment II Stockholders Approve Appreciate Deal

Although Proptech II did not disclose redemptions, the SPAC in an 8-K filing said it entered into a forward purchase agreement yesterday – two days after the shareholder vote – with Vellar Opportunity Fund SPV for 9 million shares at $10.08 each. Those funds would be used as a backstop.
Read More

Rubicon Completes Business Combination with Founder SPAC

Rubicon raised $196.8 million in gross proceeds, consisting of funds from Founder’s trust account and PIPE investments, after redemptions and prior to the payment of transaction fees and expenses and amounts payable under Founder’s $150 million forward purchase agreement.